Glucagen Hypokit

Glucagen Hypokit is a prescription medication that contains the active ingredient glucagon. It is supplied in a kit designed for intramuscular, intravenous, or subcutaneous administration and is used primarily in the European market for the rapid treatment of severe hypoglycemia.

Glucagen Hypokit is indicated for the emergency reversal of severe hypoglycemia when oral glucose is not feasible. It is used by healthcare professionals and trained caregivers in various settings.

- Acute treatment of severe hypoglycemia in diabetic patients - Emergency use when the patient is unconscious or unable to swallow - Administration by intramuscular, intravenous, or subcutaneous injection - Situations where rapid elevation of blood glucose is required - Use in hospitals, ambulances, or home settings under medical guidance

Glucagen Hypokit may cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require prompt medical attention.

Common: - Nausea or vomiting - Flushing or warmth at the injection site - Headache - Transient rise in blood pressure

Serious: - Severe allergic reaction (anaphylaxis) - Rapid heart rate (tachycardia) or palpitations - Hypotension or shock in rare cases

Before using Glucagen Hypokit, certain precautions should be considered to ensure safe administration.

- Verify the diagnosis of severe hypoglycemia before injection - Ensure proper training in injection technique and dosage preparation - Monitor blood glucose levels after administration - Use with caution in patients with known glucagon allergy - Store the kit according to manufacturer instructions to maintain potency - Keep the kit out of reach of children and unauthorized persons

Glucagen Hypokit may interact with other medications, affecting its efficacy or safety profile.

Avoid: - Beta‑blockers, which can mask typical glucagon side effects - Certain antihypertensive agents that may exacerbate blood pressure changes - Medications that cause severe nausea or vomiting, potentially complicating administration

Use with caution: - Insulin analogs, as they may influence the severity of hypoglycemia - Oral hypoglycemic agents, especially sulfonylureas - Drugs that affect hepatic glycogen stores, such as corticosteroids